Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...
Walgreens jumps as Sycamore agrees to $11.45 a share purchase Sycamore Partners agreed to acquire Walgreens Boots (WBA) in a ...
Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...
While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...
Despite comments made by a Novo Nordisk official this week, the company confirmed to BioSpace that it has no additional ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback